Gador Gador is a pharmaceutical company dedicated to the research, manufacture, and marketing of self-developed health care products. | ![]() Leti Grupo LETI (also known as LETI Pharma) is a company engaged in the production and commercialization of prescription, over-the-counter, and generic drugs for human and veterinary use. | PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. | ![]() Catalent Pharma Solutions Catalent Pharma Solutions is a company that provides drug delivery technologies and manufactures solutions for drugs, protein, cell, and gene therapy biologics, and consumer health products. | WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. | |
Founding Date | Founding Date 1940 | Founding Date 1950 | Founding Date 1985 | Founding Date 1989 | Founding Date 2010 |
Type | Type Private | Type Private | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations CUI, AR HQ Pilar, AR Providencia, CL Quito, EC Lima, PE | Locations Guarenas, VE HQ | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | Locations Somerset, US HQ | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US |
Employees | Employees 1,2071% increase | Employees 1,020 | Employees 24,5842% decrease | Employees 8,300 | Employees 12,575 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $4.7b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) ¥21.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $1.7b (FY, 2020) | Cost of goods N/A | Cost of goods ¥10b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $3b (FY, 2020) | Gross profit N/A | Gross profit ¥12b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $160.6m (FY, 2020) | Net income N/A | Net income ¥5.7b (FY, 2025) |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog N/A | Backlog $9.5b (Q3, 2021) | Backlog N/A | Backlog $18.5b (H1, 2022) |

Grupo LETI (also known as LETI Pharma) is a company engaged in the production and commercialization of prescription, over-the-counter, and generic drugs for human and veterinary use.
View companyPPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View company
Catalent Pharma Solutions is a company that provides drug delivery technologies and manufactures solutions for drugs, protein, cell, and gene therapy biologics, and consumer health products.
View companyWuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View company